Amit Singh Dang
Directeur Général chez SOLARWINDOW TECHNOLOGIES, INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Justin Frere | M | 51 | 13 ans | |
Joseph Sierchio | M | 74 | 4 ans | |
Briana L. Erickson | F | - | 13 ans | |
Robert Levine | M | 75 | 6 ans | |
Patrick Sargent | M | - | - | |
In-Jae Chung | M | 67 | 3 ans | |
James Whitaker | M | - | 5 ans | |
Alexandra Musk | F | - | 4 ans | |
Kyle Ballarta | M | - | 3 ans | |
Chulwoo Kim | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Jatinder Bhogal | M | 56 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 8 ans |
Raymond Krauss | M | 62 | 3 ans | |
Steven C. Berger | M | 63 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 1 ans |
Meetesh V. Patel | M | 49 | - | |
Frank Menzler | M | 55 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 3 ans |
Jeet S. Sidhu | M | 51 | 2 ans | |
Luis Cely | M | - |
Wayne State University (Michigan)
| 7 ans |
Gregory Wujek | M | 62 | 4 ans | |
Amit S. Dang | M | 42 |
Wayne State University (Michigan)
| 7 ans |
Gary Parmar | M | 53 | 2 ans | |
Todd Zahn | M | - |
Wayne State University (Michigan)
| 4 ans |
Derek J. Cooper | M | 48 |
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | 7 ans |
Richard Rosenblum | M | 65 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 1 ans |
James Cerna | M | 55 |
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | 1 ans |
John Patouhas | M | 57 |
Wayne State University (Michigan)
| 2 ans |
RJ Joshi | M | - |
Wayne State University (Michigan)
| 2 ans |
Jonathan Farr | M | - |
Wayne State University (Michigan)
| 3 ans |
Paul Brown | M | - |
Wayne State University (Michigan)
| 3 ans |
Harmel Rayat | M | 63 | 1 ans | |
Brent Wall | M | - |
Wayne State University (Michigan)
| 2 ans |
Hany Boutros | M | - |
Wayne State University (Michigan)
| 4 ans |
Hua Gong | M | 57 |
Wayne State University (Michigan)
| 3 ans |
James Bruno | M | 59 |
Wayne State University (Michigan)
| 4 ans |
Li Li | M | 53 |
Wayne State University (Michigan)
| 2 ans |
Timothy Reilly | M | 50 |
Wayne State University (Michigan)
| 4 ans |
Sergio Pombo | M | - | - | |
Steffens Anthony | M | - |
Wayne State University (Michigan)
| 6 ans |
Bobbie Kumar | F | - |
Wayne State University (Michigan)
| 4 ans |
William Cox | M | - |
Wayne State University (Michigan)
| 4 ans |
Janet Lynn Bien | F | 60 | 2 ans | |
Brian Weisberger | M | - |
Wayne State University (Michigan)
| 2 ans |
Bruce D. Leuchter | M | - |
Wayne State University (Michigan)
| 4 ans |
Javier Jimenez | M | 58 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 3 ans |
Donna Abelli | F | 66 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | - |
William P. Peters | M | 72 |
Wayne State University (Michigan)
| - |
Dave Stefansky | M | 52 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | 1 ans |
David Moss | M | 54 |
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | - |
Michael J. Franklin | M | - |
Wayne State University (Michigan)
| 3 ans |
Kimberly Tara | F | 54 | - | |
Christopher Michael Pillar | M | - |
Wayne State University (Michigan)
| 3 ans |
Nadia Lio | F | - |
Wayne State University (Michigan)
| 4 ans |
James G. Stevenson | M | 66 |
Wayne State University (Michigan)
| 8 ans |
Jackie Trepanier | F | - |
Wayne State University (Michigan)
| 3 ans |
Aaron Bragman | M | - |
Wayne State University (Michigan)
| 2 ans |
Brian Goss | M | 46 |
Wayne State University (Michigan)
| 4 ans |
Christine Abuel Pompa | F | - |
Wayne State University (Michigan)
| 4 ans |
Joseph Michael Perkins | M | 55 |
Wayne State University (Michigan)
| 2 ans |
Rod Lidster | M | - |
Wayne State University (Michigan)
| 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 58 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Amit Singh Dang
- Réseau Personnel